Cannabis Co. Juva Life Secures $11.8M in Financing For Operations Expansion, Clinical Research - Benzinga
Cannabis-focused pharmaceutical research and development and consumer-facing company Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) has closed a non-dilutive financing of $11.8 million, enabling it to acquire its Stockton, California, facility as well as further its clinical research on its two novel compounds.
The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: firstname.lastname@example.org